Braveheart Investment Group plc

Equities

BRH

GB00B13XV322

Investment Management & Fund Operators

Delayed London S.E. Other stock markets 05:51:27 2024-04-29 am EDT			5-day change	1st Jan Change
6.824 ^GBX	+4.98%		+9.18%	-22.01%

Mar. 06	Braveheart buys 4 million Autins shares for GBP320,000	AN
Mar. 06	Braveheart Investment Group Raises Autins Group Stake	MT

Braveheart Investment investee Paraytec updates on CX300

October 17, 2023 at 12:04 pm EDT

Braveheart Investment Group PLC - Dodworth, England-based investment company - Investee company Paraytec Ltd updates on its work in the development of potential use cases for its rapid test instrument, CX300. Explains it has been successfully tested in the detection of adeno-associated viruses, which are used in gene therapy. Notes this is important because virus-like particles such as adeno-associated viruses are used to encapsulate the new gene and deliver it into the body. Points out the target is to market the CX300 for use by all gene therapy manufacturers for in-process assessment of the quality of their adeno-associated virus products during research, development and, in due course, manufacturing.

Current stock price: 10.10 pence

12-month change: up 23%

By Jeremy Cutler, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Latest news about Braveheart Investment Group plc

Braveheart buys 4 million Autins shares for GBP320,000	Mar. 06	AN
Braveheart Investment Group Raises Autins Group Stake	Mar. 06	MT
Braveheart Investment Group plc (AIM : BRH) acquired 7.33% skate in Autins Group plc (AIM : AUTG) for approximately £0.32 million.	Mar. 05	CI
Beowulf raises funds for Kallak iron ore project	Mar. 04	AN
Beowulf ups Vardar stake; Impellam buyout nears	Mar. 04	AN
Braveheart Investment Group Closes Sale of Phasefocus Holdings Unit to Bruker UK	Mar. 04	MT
Bruker Uk Limited completed the acquisition of Phasefocus Holdings Limited from Braveheart Investment Group plc and other shareholders.	Mar. 03	CI
Braveheart Investment to sell Phasefocus for GBP5 million	Dec. 22	AN
Braveheart Investment to Receive GBP2 Million Via Subsidiary Sale	Dec. 22	MT
Braveheart Investment Announces Sale Of Phasefocus	Dec. 22	RE
Bruker Uk Limited entered into a conditional sale and purchase agreement to acquire Phasefocus Holdings Limited from Braveheart Investment Group plc and other shareholders for £5 million.	Dec. 21	CI
EARNINGS AND TRADING: Redx full year revenue tumbles; loss widens	Dec. 15	AN
EARNINGS AND TRADING: abrdn Diversified Income to begin wind-down	Dec. 14	AN
Earnings Flash (BRH.L) BRAVEHEART INVESTMENT GROUP Reports Fiscal H1 Revenue GBP46,494	Dec. 14	MT
Earnings Flash (BRH.L) BRAVEHEART INVESTMENT GROUP Posts Fiscal H1 Loss GBX-1.15	Dec. 14	MT
Braveheart Investment Group plc Reports Earnings Results for the Half Year Ended September 30, 2023	Dec. 14	CI
Braveheart Investment firm gets first CX300 detector sales contract	Nov. 29	AN
Braveheart Investment investee Paraytec updates on CX300	23-10-17	AN
Braveheart Investment investee Kirkstall develops new model	23-09-08	AN
Braveheart invests GBP150,000 in Phasefocus for cancer-focused assay	23-08-21	AN
UK's Braveheart Investment Takes Additional Stake in Phasefocus	23-08-21	MT
Phasefocus Holdings Limited announced that it has received £0.15 million in funding from Braveheart Investment Group plc	23-08-20	CI
Limitless Earth loss widens; Black Sea NAV rises	23-07-28	AN
Braveheart Investment opts for "masterful inactivity" as profit rises	23-07-03	AN
Braveheart Investment Group plc Reports Earnings Results for the Full Year Ended March 31, 2023	23-07-03	CI

Chart Braveheart Investment Group plc

Duration

Period

More charts

Company Profile

Braveheart Investment Group plc is a United Kingdom-based private equity and venture capital company. The Company divides its investments into two categories, namely strategic investments and portfolio investments. Its strategic investments include companies, including Paraytec Limited (Paraytec), Kirkstall Limited, Autins Group plc, Aukett Swanke Group plc and Image Scan Group plc. Paraytec develops specialist detectors for the analytical and life sciences instrumentation markets. Kirkstall Limited operates in the organ-on-a-chip market where it has developed Quasi Vivo, a system of chambers for cell and tissue culture in laboratories. Autins Group plc specializes in solving acoustic and thermal problems in the automotive industry and other specialist applications. Aukett Swanke Group plc provides architectural and interior design services in the primary international market sectors of offices, residential, education, industrial, hospitality and mixed use or hybrid developments.

Sector

Investment Management & Fund Operators

Calendar

2024-06-13 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Investment Management & Fund Operators

	1st Jan change	Capi.
BRAVEHEART INVESTMENT GROUP PLC	-22.01%	5.16M
BLACKROCK, INC.	-6.03%	113B
UBS GROUP AG	-3.68%	87.91B
APOLLO GLOBAL MANAGEMENT, INC.	+20.42%	63.85B
BROOKFIELD CORPORATION	+5.29%	61.9B
BANK OF NEW YORK MELLON CORPORATION (THE)	+10.12%	42.86B
AMERIPRISE FINANCIAL, INC.	+7.95%	40.84B
3I GROUP PLC	+19.17%	34.58B
T. ROWE PRICE GROUP INC.	+5.88%	25.46B
STATE STREET CORPORATION	-5.25%	22.13B

Other Investment Management & Fund Operators